A Risk-Adapted Protocol of Prophylactic Zoledronic Acid Prevents Bone Mineral Density Loss Post Allograft: Results of the ALLG Bm07 Phase II Prospective Trial

Authors:
  • EWEric Wong
    Eric Wong
  • BBBelinda Butcher
    Belinda Butcher
  • BKBereha Khodr
    Bereha Khodr
  • ABAshish Bajel
    Ashish Bajel
  • MHMark Hertzberg
    Mark Hertzberg
  • SPSushrut Patil
    Sushrut Patil
  • ADAlwyn D'SOuza
    Alwyn D'SOuza
  • PGPeter Ganley
    Peter Ganley
  • PEPeter Ebeling
    Peter Ebeling
  • AGAndrew Grigg
    Andrew Grigg

Abstract
No abstract available